227 related articles for article (PubMed ID: 23204245)
1. Validity of medication adherence self-reports in adults with type 2 diabetes.
Gonzalez JS; Schneider HE; Wexler DJ; Psaros C; Delahanty LM; Cagliero E; Safren SA
Diabetes Care; 2013 Apr; 36(4):831-7. PubMed ID: 23204245
[TBL] [Abstract][Full Text] [Related]
2. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).
Cohen HW; Shmukler C; Ullman R; Rivera CM; Walker EA
Diabet Med; 2010 Feb; 27(2):210-6. PubMed ID: 20546266
[TBL] [Abstract][Full Text] [Related]
3. Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.
Nagrebetsky A; Griffin S; Kinmonth AL; Sutton S; Craven A; Farmer A
Diabetes Res Clin Pract; 2012 May; 96(2):119-28. PubMed ID: 22261095
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
Aikens JE; Piette JD
Diabet Med; 2013 Mar; 30(3):338-44. PubMed ID: 23075262
[TBL] [Abstract][Full Text] [Related]
5. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
6. The association between diabetes metabolic control and drug adherence in an indigent population.
Schectman JM; Nadkarni MM; Voss JD
Diabetes Care; 2002 Jun; 25(6):1015-21. PubMed ID: 12032108
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
9. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.
Bogner HR; Morales KH; de Vries HF; Cappola AR
Ann Fam Med; 2012; 10(1):15-22. PubMed ID: 22230826
[TBL] [Abstract][Full Text] [Related]
10. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
11. Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimen.
Aikens JE; Perkins DW; Piette JD; Lipton B
Diabet Med; 2008 Nov; 25(11):1324-9. PubMed ID: 19046223
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
13. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
[TBL] [Abstract][Full Text] [Related]
14. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes.
Egede LE; Gebregziabher M; Hunt KJ; Axon RN; Echols C; Gilbert GE; Mauldin PD
Diabetes Care; 2011 Apr; 34(4):938-43. PubMed ID: 21335370
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study.
Heisler M; Faul JD; Hayward RA; Langa KM; Blaum C; Weir D
Arch Intern Med; 2007 Sep; 167(17):1853-60. PubMed ID: 17893306
[TBL] [Abstract][Full Text] [Related]
17. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
[TBL] [Abstract][Full Text] [Related]
19. Patient factors and glycaemic control--associations and explanatory power.
Rogvi S; Tapager I; Almdal TP; Schiøtz ML; Willaing I
Diabet Med; 2012 Oct; 29(10):e382-9. PubMed ID: 22540962
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
